UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 442

Sortiert nach

Epidemiology of Methicillin-Resistant Staphylococcus aureus

Clinical infectious diseases, 2008-06, Vol.46 (Supplement-5), p.S344-S349

2008

Volltextzugriff (PDF)

Single-Dose Oritavancin Versus 7–10 Days of Vancomycin in the Treatment of Gram-Positive Acute Bacterial Skin and Skin Structure Infections: The SOLO II Noninferiority Study

Clinical infectious diseases, 2015-01, Vol.60 (2), p.254-262

2015

Volltextzugriff (PDF)

Enterococcal endocarditis in the beginning of the 21st century: analysis from the International Collaboration on Endocarditis-Prospective Cohort Study

Clinical microbiology and infection, 2013-12, Vol.19 (12), p.1140-1147

2013

Volltextzugriff (PDF)

Single-Dose Oritavancin in the Treatment of Acute Bacterial Skin Infections

The New England journal of medicine, 2014-06, Vol.370 (23), p.2180-2190

2014

Volltextzugriff (PDF)

Exebacase for patients with Staphylococcus aureus bloodstream infection and endocarditis

The Journal of clinical investigation, 2020-07, Vol.130 (7), p.3750-3760

2020

Volltextzugriff (PDF)

Integrated Analysis of CANVAS 1 and 2: Phase 3, Multicenter, Randomized, Double-Blind Studies to Evaluate the Safety and Efficacy of Ceftaroline versus Vancomycin plus Aztreonam in Complicated Skin and Skin-Structure Infection

Clinical infectious diseases, 2010-09, Vol.51 (6), p.641-650

2010

Volltextzugriff (PDF)

Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial

The Lancet infectious diseases, 2014-08, Vol.14 (8), p.696-705

2014

Volltextzugriff (PDF)

Staphylococcus aureus Bloodstream Infections: Definitions and Treatment

Clinical infectious diseases, 2009-05, Vol.48 (Supplement-4), p.S254-S259

Corey, G. Ralph

2009

Volltextzugriff (PDF)

In Vitro Activity of Eravacycline against Gram-Positive Bacteria Isolated in Clinical Laboratories Worldwide from 2013 to 2017

Antimicrobial agents and chemotherapy, 2020-02, Vol.64 (3)

2020

Volltextzugriff (PDF)

Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial

JAMA : the journal of the American Medical Association, 2013-04, Vol.309 (13), p.1368

2013

Volltextzugriff (PDF)

Analysis of the phase 3 ESTABLISH trials of tedizolid versus linezolid in acute bacterial skin and skin structure infections

Antimicrobial agents and chemotherapy, 2015-02, Vol.59 (2), p.864-871

2015

Volltextzugriff (PDF)

Working formulation for the standardization of definitions of infections in patients using ventricular assist devices

The Journal of heart and lung transplantation, 2011-04, Vol.30 (4), p.375-384

2011

Volltextzugriff (PDF)

Good Studies Evaluate the Disease While Great Studies Evaluate the Patient: Development and Application of a Desirability of Outcome Ranking Endpoint for Staphylococcus aureus Bloodstream Infection

Clinical infectious diseases, 2019-05, Vol.68 (10), p.1691-1698

2019

Volltextzugriff (PDF)

Telavancin Versus Vancomycin for the Treatment of Complicated Skin and Skin-Structure Infections Caused by Gram-Positive Organisms

Clinical infectious diseases, 2008-06, Vol.46 (11), p.1683-1693

2008

Volltextzugriff (PDF)

Contemporary clinical profile and outcome of prosthetic valve endocarditis

JAMA : the journal of the American Medical Association, 2007-03, Vol.297 (12), p.1354

2007

Volltextzugriff (PDF)

Persistent Bacteremia Due to Methicillin-Resistant Staphylococcus aureus Infection Is Associated with agr Dysfunction and Low-Level In Vitro Resistance to Thrombin-Induced Platelet Microbicidal Protein

The Journal of infectious diseases, 2004-09, Vol.190 (6), p.1140-1149

2004

Volltextzugriff (PDF)

Telavancin versus Vancomycin for Hospital-Acquired Pneumonia due to Gram-positive Pathogens

Clinical infectious diseases, 2011-01, Vol.52 (1), p.31-40

2011

Volltextzugriff (PDF)

Effect of Algorithm-Based Therapy vs Usual Care on Clinical Success and Serious Adverse Events in Patients with Staphylococcal Bacteremia: A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2018-09, Vol.320 (12), p.1249

2018

Volltextzugriff (PDF)

Inoculum Effect with Cefazolin among Clinical Isolates of Methicillin-Susceptible Staphylococcus aureus: Frequency and Possible Cause of Cefazolin Treatment Failure

Antimicrobial Agents and Chemotherapy, 2009-08, Vol.53 (8), p.3437-3441

2009

Volltextzugriff (PDF)

Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus

The New England journal of medicine, 2006-08, Vol.355 (7), p.653-665

2006

Volltextzugriff (PDF)

High-Dose Daptomycin Therapy for Left-Sided Infective Endocarditis: a Prospective Study from the International Collaboration on Endocarditis

Antimicrobial Agents and Chemotherapy, 2013-12, Vol.57 (12), p.6213-6222

2013

Volltextzugriff (PDF)

Staphylococcus aureus endocarditis: a consequence of medical progress

JAMA : the journal of the American Medical Association, 2005-06, Vol.293 (24), p.3012

2005

Volltextzugriff (PDF)

Methicillin-Susceptible Staphylococcus aureus Endocarditis Isolates Are Associated With Clonal Complex 30 Genotype and a Distinct Repertoire of Enterotoxins and Adhesins

The Journal of infectious diseases, 2011-09, Vol.204 (5), p.704-713

2011

Volltextzugriff (PDF)

Presence of Genes Encoding the Panton-Valentine Leukocidin Exotoxin Is Not the Primary Determinant of Outcome in Patients with Complicated Skin and Skin Structure Infections Due to Methicillin-Resistant Staphylococcus aureus: Results of a Multinational Trial

Journal of Clinical Microbiology, 2009-12, Vol.47 (12), p.3952-3957

2009

Volltextzugriff (PDF)

Determination of an Inoculum Effect with Various Cephalosporins among Clinical Isolates of Methicillin-Susceptible Staphylococcus aureus

Antimicrobial Agents and Chemotherapy, 2010-05, Vol.54 (5), p.2206-2208

2010

Volltextzugriff (PDF)

1 – 25 von 442

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(396)
Mit Volltextzugriff
(396)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(294)
Life Sciences & Biomedicine
(274)
Humans
(258)
Male
(159)
Infectious Diseases
(151)
Female
(148)
Biological And Medical Sciences
(140)
Medical Sciences
(136)
Middle Aged
(125)
Microbiology
(112)
Adult
(103)
Aged
(94)
Staphylococcus Aureus
(82)
Immunology
(65)
Infections
(60)
Treatment Outcome
(58)
Anti-Bacterial Agents - Therapeutic Use
(54)
Bacterial Diseases
(51)
Human Bacterial Diseases
(51)
Endocarditis
(46)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Epidemiology of Methicillin-Resistant Staphylococcus aureus

Single-Dose Oritavancin Versus 7–10 Days of Vancomycin in the Treatment of Gram-Positive Acute Bacterial Skin and Skin Structure Infections: The SOLO II Noninferiority Study

Enterococcal endocarditis in the beginning of the 21st century: analysis from the International Collaboration on Endocarditis-Prospective Cohort Study

Single-Dose Oritavancin in the Treatment of Acute Bacterial Skin Infections

Exebacase for patients with Staphylococcus aureus bloodstream infection and endocarditis

Integrated Analysis of CANVAS 1 and 2: Phase 3, Multicenter, Randomized, Double-Blind Studies to Evaluate the Safety and Efficacy of Ceftaroline versus Vancomycin plus Aztreonam in Complicated Skin and Skin-Structure Infection

Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial

Staphylococcus aureus Bloodstream Infections: Definitions and Treatment

In Vitro Activity of Eravacycline against Gram-Positive Bacteria Isolated in Clinical Laboratories Worldwide from 2013 to 2017

Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial

Analysis of the phase 3 ESTABLISH trials of tedizolid versus linezolid in acute bacterial skin and skin structure infections

Working formulation for the standardization of definitions of infections in patients using ventricular assist devices

Good Studies Evaluate the Disease While Great Studies Evaluate the Patient: Development and Application of a Desirability of Outcome Ranking Endpoint for Staphylococcus aureus Bloodstream Infection

Telavancin Versus Vancomycin for the Treatment of Complicated Skin and Skin-Structure Infections Caused by Gram-Positive Organisms

Contemporary clinical profile and outcome of prosthetic valve endocarditis

Persistent Bacteremia Due to Methicillin-Resistant Staphylococcus aureus Infection Is Associated with agr Dysfunction and Low-Level In Vitro Resistance to Thrombin-Induced Platelet Microbicidal Protein

Telavancin versus Vancomycin for Hospital-Acquired Pneumonia due to Gram-positive Pathogens

Effect of Algorithm-Based Therapy vs Usual Care on Clinical Success and Serious Adverse Events in Patients with Staphylococcal Bacteremia: A Randomized Clinical Trial

Inoculum Effect with Cefazolin among Clinical Isolates of Methicillin-Susceptible Staphylococcus aureus: Frequency and Possible Cause of Cefazolin Treatment Failure

Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus

High-Dose Daptomycin Therapy for Left-Sided Infective Endocarditis: a Prospective Study from the International Collaboration on Endocarditis

Staphylococcus aureus endocarditis: a consequence of medical progress

Methicillin-Susceptible Staphylococcus aureus Endocarditis Isolates Are Associated With Clonal Complex 30 Genotype and a Distinct Repertoire of Enterotoxins and Adhesins

Presence of Genes Encoding the Panton-Valentine Leukocidin Exotoxin Is Not the Primary Determinant of Outcome in Patients with Complicated Skin and Skin Structure Infections Due to Methicillin-Resistant Staphylococcus aureus: Results of a Multinational Trial

Determination of an Inoculum Effect with Various Cephalosporins among Clinical Isolates of Methicillin-Susceptible Staphylococcus aureus

Suchergebnisse filtern